Trial Profile
Efficacy and safety of sitagliptin as add-on therapy to multiple daily insulin injections therapy in inadequately controlled Japanese subjects with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2019
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 08 Sep 2019 Status changed from recruiting to completed.
- 16 Mar 2013 New trial record